Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2011. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on share repurchase activity and capital structure metrics:
- Shares Purchased: 500,000 ordinary shares on December 1, 2011.
- Price Range: Highest price paid was 1,418 pence per share; lowest price paid was 1,407.5 pence per share.
- Treasury Holdings (Settled): 528,482,927 shares (9.48% of total issued share capital).
- Treasury Holdings (Including Unsettled): 529,882,927 shares (10.50% of current total voting rights).
- Shares in Issue: 5,048,024,213 shares (excluding treasury shares).
Material Changes
The primary material change reported is the increase in the company's treasury share holdings following the December 1, 2011, purchase. This transaction increased the percentage of total voting rights held in treasury to 10.50% when including unsettled shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares in issue (5,048,024,213) for calculating disclosure thresholds under FSA rules.
- Confirm the current percentage of voting rights held in treasury (10.50% including unsettled shares).
- Review the price paid per share (1,407.5 to 1,418 pence) against market prices on December 1, 2011.
- Note that this filing does not contain financial performance data; refer to Form 20-F for annual results.